These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27806064)

  • 1. Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs.
    Cong ME; Pau CP; Heneine W; García-Lerma JG
    PLoS One; 2016; 11(11):e0164821. PubMed ID: 27806064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.
    García-Lerma JG; Otten RA; Qari SH; Jackson E; Cong ME; Masciotra S; Luo W; Kim C; Adams DR; Monsour M; Lipscomb J; Johnson JA; Delinsky D; Schinazi RF; Janssen R; Folks TM; Heneine W
    PLoS Med; 2008 Feb; 5(2):e28. PubMed ID: 18254653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis.
    Zheng Q; Ruone S; Switzer WM; Heneine W; García-Lerma JG
    Retrovirology; 2012 May; 9():40. PubMed ID: 22571771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis.
    Curtis KA; Kennedy MS; Luckay A; Cong ME; Youngpairoj AS; Zheng Q; Smith J; Hanson D; Heneine W; Owen SM; García-Lerma JG
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):355-62. PubMed ID: 21637113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunity.
    Ross TM; Pereira LE; Luckay A; McNicholl JM; García-Lerma JG; Heneine W; Eugene HS; Pierce-Paul BR; Zhang J; Hendry RM; Smith JM
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1072-81. PubMed ID: 24914761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis.
    Radzio J; Henning T; Jenkins L; Ellis S; Farshy C; Phillips C; Holder A; Kuklenyik S; Dinh C; Hanson D; McNicholl J; Heneine W; Papp J; Kersh EN; García-Lerma JG
    J Infect Dis; 2016 May; 213(10):1541-5. PubMed ID: 26743846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simian/human immunodeficiency virus containing the K65R mutation in macaques.
    Cong ME; Mitchell J; Sweeney E; Bachman S; Hanson DL; Heneine W; García-Lerma JG
    J Infect Dis; 2013 Aug; 208(3):463-7. PubMed ID: 23633402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques.
    Kersh EN; Luo W; Adams DR; Mitchell J; Garcia-Lerma JG; Heneine W; Folks TM; Butera S; Otten RA
    AIDS Res Hum Retroviruses; 2008 Apr; 24(4):543-6. PubMed ID: 18370590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.
    Massud I; Cong ME; Ruone S; Holder A; Dinh C; Nishiura K; Khalil G; Pan Y; Lipscomb J; Johnson R; Deyounks F; Rooney JF; Babusis D; Park Y; McCallister S; Callebaut C; Heneine W; García-Lerma JG
    J Infect Dis; 2019 Oct; 220(11):1826-1833. PubMed ID: 31362305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.
    Radzio J; Aung W; Holder A; Martin A; Sweeney E; Mitchell J; Bachman S; Pau CP; Heneine W; García-Lerma JG
    PLoS One; 2012; 7(12):e50632. PubMed ID: 23226529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis.
    Kersh EN; Luo W; Zheng Q; Adams DR; Hanson D; Youngpairoj AS; Cong ME; Butler K; Hendry RM; McNicholl JM; Heneine W; Garcia-Lerma JG
    J Infect Dis; 2012 Sep; 206(5):770-9. PubMed ID: 22740713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
    Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
    J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.
    Tsegaye TS; Butler K; Luo W; Radzio J; Srinivasan P; Sharma S; Aubert RD; Hanson DL; Dobard C; Garcia-Lerma JG; Heneine W; McNicholl JM; Kersh EN
    J Acquir Immune Defic Syndr; 2015 Aug; 69(4):385-94. PubMed ID: 25886925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
    Parikh UM; Mellors JW
    Curr Opin HIV AIDS; 2016 Jan; 11(1):49-55. PubMed ID: 26633640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection.
    Massud I; Mitchell J; Babusis D; Deyounks F; Ray AS; Rooney JF; Heneine W; Miller MD; García-Lerma JG
    J Infect Dis; 2016 Oct; 214(7):1058-62. PubMed ID: 27465645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxis.
    Kersh EN; Adams DR; Youngpairoj AS; Luo W; Zheng Q; Cong ME; Aung W; Mitchell J; Otten R; Hendry RM; Heneine W; McNicholl J; Garcia-Lerma JG
    PLoS One; 2011 Apr; 6(4):e19295. PubMed ID: 21541293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy.
    Kearney MF; Anderson EM; Coomer C; Smith L; Shao W; Johnson N; Kline C; Spindler J; Mellors JW; Coffin JM; Ambrose Z
    Retrovirology; 2015 Nov; 12():93. PubMed ID: 26559632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures.
    Srinivasan P; Moss JA; Gunawardana M; Churchman SA; Yang F; Dinh CT; Mitchell JM; Zhang J; Fanter R; Miller CS; Butkyavichene I; McNicholl JM; Smith TJ; Baum MM; Smith JM
    PLoS One; 2016; 11(6):e0157061. PubMed ID: 27275923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double oral administration of emtricitabine/tenofovir prior to virus exposure protects against highly pathogenic simian/human immunodeficiency virus infection in macaques.
    Nakasone T; Murakami T; Yamamoto N
    Jpn J Infect Dis; 2012 Jul; 65(4):345-9. PubMed ID: 22814162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Frequency of Drug-Resistant Variants Selected by Long-Acting Rilpivirine in Macaques Infected with Simian Immunodeficiency Virus Containing HIV-1 Reverse Transcriptase.
    Melody K; McBeth S; Kline C; Kashuba AD; Mellors JW; Ambrose Z
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7762-70. PubMed ID: 26438501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.